A recent study from the University of Maine and other institutions has shed light on the potential benefits of B vitamins in lowering blood pressure, particularly in people who struggle with drug-resistant hypertension.
This finding is significant because it offers a possible new way to manage a condition that affects a large portion of the global population.
Hypertension, or high blood pressure, is a common condition that can lead to serious health issues such as heart disease, stroke, and kidney problems. For many people, controlling blood pressure is a challenge, even with medication.
About 12.8% of the world’s population has drug-resistant hypertension, meaning their blood pressure remains high despite taking three different types of medication. This makes managing the condition particularly difficult.
One of the factors that can influence blood pressure is a compound called homocysteine. Homocysteine is involved in the body’s processing of vitamins, particularly B vitamins such as B6, B12, folate, and riboflavin (B2).
When homocysteine levels are too high, it can cause problems like the narrowing of small blood vessels, which can lead to high blood pressure and other cardiovascular issues.
High homocysteine levels can be caused by genetic factors or a lack of these essential B vitamins. Fortunately, lowering homocysteine levels can be achieved relatively easily and inexpensively through vitamin supplementation.
This makes B vitamins a promising option for people who have difficulty controlling their blood pressure with traditional medications alone.
The study reviewed existing research on the relationship between B vitamins, homocysteine levels, and blood pressure. The researchers found that taking B vitamins—specifically B2, B6, folate, and B12—can effectively lower blood pressure by 6 to 13 mmHg.
This is a significant reduction, especially for people with drug-resistant hypertension, where even small improvements can make a big difference.
Interestingly, the study also highlighted the need to reconsider what is considered a “normal” level of homocysteine. Currently, many laboratories define normal homocysteine levels as up to 11.4 μmol/L.
However, the study suggests that the upper limit should be lowered to 10 μmol/L or even less, as lower homocysteine levels might offer better protection against high blood pressure and related health risks.
While the findings are promising, the researchers emphasize that anyone considering vitamin supplements for blood pressure management should do so under the guidance of a doctor or qualified healthcare provider.
This is particularly important for those with drug-resistant hypertension, as managing the condition often requires a combination of treatments tailored to the individual.
In summary, the study offers hope that B vitamins could be a valuable addition to the treatment options for people with hard-to-control high blood pressure.
By lowering homocysteine levels, these vitamins might help reduce blood pressure and protect against the risks of heart disease and stroke. However, as with any treatment, it’s important to consult with a healthcare professional to determine the best approach for your specific needs.
If you care about high blood pressure, please read studies about potatoes and high blood pressure, and top 10 choices for a blood pressure-friendly diet
For more information about high blood pressure, please see recent studies about impact of vitamins on high blood pressure you need to know, and the powerful link between high blood pressure and a potassium-rich diet.
Copyright © 2024 Knowridge Science Report. All rights reserved.
